Poging GOUD - Vrij

China shows unity with Russia and North Korea, but divisions linger

Mint Hyderabad

|

September 09, 2025

Xi's embrace of Putin, Kim sent a powerful message, but those relationships remain, for now, far short of a military or political alliance

- Yaroslav Trofimov

The pageantry of China's Xi Jinping, flanked by leaders of fellow nuclear powers Russia and North Korea as intercontinental ballistic missiles rolled through flag-waving crowds on Tiananmen Square, marked a new phase in the redrawing of the international order.

No longer circumspect about supporting his two rogue neighbors, Xi flaunted Beijing's growing links with Moscow and Pyongyang—both of them subjected to Western sanctions, both of them engaged in a bloody war against Ukraine and both of them potentially useful to China in a possible conflict with the U.S.

Despite becoming tighter, those relationships remain—for now at least—far short of an actual military or political alliance that could impose its will on the Eurasian landmass, the world's wealthiest and most populous region.

"China is very cautious about working with these two countries. Unlike what is depicted in the West as them being allies, China is not in the same camp. Its view of warfare and security issues is very different from theirs," said Tang Xiaoyang, chair of the department of international relations at Tsinghua University, pointing out that Beijing hasn't fought a war for more than four decades. "What China wants is stability on its borders."

The gap between Beijing's aspirations and those of its junior partners, however, is clearly narrowing, Western diplomats and China watchers say. How fast and to what extent those contradictions could be bridged will determine the shape of the international system that is emerging after President Trump upended Washington's network of alliances in Asia and Europe.

MEER VERHALEN VAN Mint Hyderabad

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size